Center to Fight Vector-Borne Diseases in the Midwest
Official title: CK22-005, The Midwest Center of Excellence for Vector-Borne Disease
Funded at University of Wisconsin-Madison · NIH-11626687 · Data updated 2026-11-12
A Midwest program brings researchers, public health teams, and vector-control groups together to prevent diseases spread by ticks and mosquitoes.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project start | July 1, 2022 |
| Project end | June 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $519,000 |
| NIH project number | 6U01CK000651-05M001 |
| Project ID | NIH-11626687 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal participants are residents in the Midwest at risk for vector-borne diseases, including people living in areas with ticks and mosquitoes.
✕Less likely to help
Some communities may not see immediate benefits while research activities are ongoing.
What this research studies
This grant funds a regional collaboration across several Midwestern states to understand and reduce the risk of diseases spread by ticks and mosquitoes. Researchers will study how climate and weather patterns influence vector populations and disease transmission, and they'll develop and test practical tools to prevent human exposure. The Center also aims to translate research findings into accessible outreach materials for public health teams and communities. Participation could involve data sharing, field studies, and collaboration with local health departments to test prevention strategies.
Why it matters
Potential benefit: If successful, the project could lead to better ways to prevent vector-borne illnesses in the Midwest and faster deployment of effective control measures.
How similar studies have gone: Previous work shows that understanding local vectors and climate factors can improve prevention efforts, though regional applicability may vary.
Where this research is happening
-
University of Wisconsin-Madison
Madison, United States Active
Researchers
- Principal investigator: Paskewitz, Susan M — University of Wisconsin-Madison
- Study coordinator: Paskewitz, Susan M
Related research
Other NIH-funded projects on the same topics.
-
BRAVE Innovation Center for Viral Resistance in Chickens
A center at UW–Madison aims to create chickens genetically resistant to avian viruses like H5N1 by identifying host genes involved in virus replication using genome-wide CRISPR screening.
-
Globally useful predictor for cervical cancer treatment response
This project aims to develop a simple predictive signature to personalize treatment for locally advanced cervical cancer using easy tests and imaging.
-
Neutrophil development with stem cells to understand their behavior
Researchers are studying how neutrophils, a type of immune cell, develop from stem cells to better understand why they can help or harm in infections and inflammatory diseases.
-
WREN: Expanding Research Capacity in Rural Primary Care Clinics
A nationwide network in Wisconsin will strengthen rural primary care clinics to participate in real-world research and bring more clinical trials to communities.
-
Targeting early oral GVHD to improve mouth health after stem cell transplant
A study at UW–Madison will explore why some transplant patients develop painful oral GVHD and test ideas to prevent and lessen mouth-related problems.
-
SSRI use during pregnancy: effects on placental blood flow and inflammation
This grant studies how antidepressants (SSRIs) used during pregnancy might affect the placenta and inflammation, and whether a 5-HT2 receptor blocker could mitigate any negative effects.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.